The long-term goal of this project is the elucidation of the molecular mechanisms by which the snake-venom derived, polypeptide alpha -neurotoxins block nicotinic acetylcholine receptor (nAChR) function. We will focus on the prototypical long-chain alpha -neurotoxin, alpha -bungarotoxin (Bgtx), the """"""""gold standard"""""""" of alpha -neurotoxins. Bgtx has been used extensively in the study of muscle-type nAChRs and a subset of neuronal nAChRs sensitive to Bgtx inhibition (e.g., alpha -7containing nAChRs). The questions that we intend to address are: 1.) Which specific residues and general structural and dynamic features in Bgtx are important for recognition and block of Bgtx-sensitive nAChRs? 2.) Can the receptor specificity of Bgtx be altered through mutagenesis to produce """"""""gain of function"""""""" variants capable of interacting in a selective manner with neuronal nAChRs that are normally insensitive to Bgtx? and 3.) How do Bgtx mutations that disrupt or significantly alter toxin activity affect the structure and conformational flexibility of Bgtx? We will pursue a structure-function analysis of Bgtx, utilizing site-directed mutagenesis of recombinant Bgtx produced in Pichia pastoris and double mutant cycle analysis to identify sites responsible for the high-affinity neuromuscular blockade produced by this alpha -neurotoxin. We also intend to identify and characterize """"""""gain of function"""""""" mutations of Bgtx which enable the recognition and functional inhibition of neuronal nAChRs that are otherwise insensitive to blockade by native Bgtx. This approach should lead to a new battery of toxins that differentially bind to the various neuronal nAChR subunit combinations. We plan to determine the structure of the recombinant Bgtx by multidimensional NMR, to compare this structure to the NMR solution structure of native Bgtx, and to analyze the backbone dynamics of recombinant Bgtx metabolically labeled with15N. Labeled Bgtx would also allow a characterization of atomic motions within its various functionally important regions. Local confirmational flexibility in Bgtx may be an important factor in the mechanism of Bgtx/receptor recognition and binding and could very well contribute both to the high affinity of Bgtx and to its ability to bind to a large number of nAChRs of varying primary structure. The proposed studies promise to shed light on the fundamental mechanisms by which protein alpha -neurotoxins interact tightly and specifically with their target sites on the cell surface. This information will be useful in providing valuable models for drug design efforts and in developing new pharmacological tools for the study of neuronal nAChRs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS034348-04A1
Application #
6041563
Study Section
Special Emphasis Panel (ZRG1-MDCN-5 (01))
Program Officer
Kitt, Cheryl A
Project Start
1996-05-01
Project End
2002-11-30
Budget Start
1999-12-10
Budget End
2000-12-31
Support Year
4
Fiscal Year
2000
Total Cost
$235,798
Indirect Cost
Name
Brown University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912
Sanders, Tanya; Hawrot, Edward (2004) A novel pharmatope tag inserted into the beta4 subunit confers allosteric modulation to neuronal nicotinic receptors. J Biol Chem 279:51460-5
Zeng, Haoyu; Hawrot, Edward (2002) NMR-based binding screen and structural analysis of the complex formed between alpha-cobratoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica. J Biol Chem 277:37439-45
Moise, Leonard; Piserchio, Andrea; Basus, Vladimir J et al. (2002) NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor. J Biol Chem 277:12406-17
Zeng, H; Moise, L; Grant, M A et al. (2001) The solution structure of the complex formed between alpha-bungarotoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica. J Biol Chem 276:22930-40
Levandoski, M M; Caffery, P M; Rogowski, R S et al. (2000) Recombinant expression of alpha-bungarotoxin in Pichia pastoris facilitates identification of mutant toxins engineered to recognize neuronal nicotinic acetylcholine receptors. J Neurochem 74:1279-89
Grant, M A; Gentile, L N; Shi, Q L et al. (1999) Expression and spectroscopic analysis of soluble nicotinic acetylcholine receptor fragments derived from the extracellular domain of the alpha-subunit. Biochemistry 38:10730-42
Levandoski, M M; Lin, Y; Moise, L et al. (1999) Chimeric analysis of a neuronal nicotinic acetylcholine receptor reveals amino acids conferring sensitivity to alpha-bungarotoxin. J Biol Chem 274:26113-9
Rosenthal, J A; Levandoski, M M; Chang, B et al. (1999) The functional role of positively charged amino acid side chains in alpha-bungarotoxin revealed by site-directed mutagenesis of a His-tagged recombinant alpha-bungarotoxin. Biochemistry 38:7847-55
Hawrot, E; Xiao, Y; Shi, Q L et al. (1998) Demonstration of a tandem pair of complement protein modules in GABA(B) receptor 1a. FEBS Lett 432:103-8